Next IFCC webinar on “Clinical Applications of Thrombosis and Hemostasis” will be held on June 6, 2021.
Thrombosis and hemostasis tests are of importance for the diagnosis of hemorrhagic diseases and disseminated intravascular coagulation (DIC). They are laboratory determinants for the mechanism of thrombosis occurrence, the classification and diagnosis of thrombotic diseases and thrombophilia, as well as the indices of the monitoring of anticoagulant therapy. Several studies showed that thromboembolic events were a serious complication of coronavirus disease 2019 (COVID-19). Autopsy revealed that the death was associated with pulmonary thromboembolism and DIC. In this webinar will provide an overview on the clinical application of thrombosis and hemostasis tests in the monitoring of new oral anticoagulants, in the diagnosis of thrombosis and hemostasis, and the performance of thrombosis and hemostasis tests in COVID-19 patients.
Please ensure you register to attend the live event and have access to the recording and to the certificate.
The IFCC Live Webinar Series is partially sponsored by Siemens and Boston Children's Hospital